AVRICORE HEALTH Financials
8VP1 Stock | EUR 0.09 0.01 10.31% |
AVRICORE |
Understanding current and past AVRICORE HEALTH Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AVRICORE HEALTH's financial statements are interrelated, with each one affecting the others. For example, an increase in AVRICORE HEALTH's assets may result in an increase in income on the income statement.
The data published in AVRICORE HEALTH's official financial statements usually reflect AVRICORE HEALTH's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AVRICORE HEALTH INC. For example, before you start analyzing numbers published by AVRICORE accountants, it's critical to develop an understanding of what AVRICORE HEALTH's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of AVRICORE HEALTH's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AVRICORE HEALTH's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AVRICORE HEALTH's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AVRICORE HEALTH INC. Please utilize our Beneish M Score to check the likelihood of AVRICORE HEALTH's management manipulating its earnings.
AVRICORE HEALTH Stock Summary
AVRICORE HEALTH competes with Cal-Maine Foods, Insteel Industries, and JAPAN TOBACCO. Avricore Health Inc. manufactures and sells over-the-counter products in Canada. Avricore Health Inc. was founded in 1996 and is headquartered in Vancouver, Canada. AVRICORE HEALTH operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.Instrument | Germany Stock View All |
Exchange | Frankfurt Exchange |
ISIN | CA0545211090 |
Business Address | 789 West Pender |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Benchmark | NYSE Composite |
Website | www.avricorehealth.com |
Phone | 604 247 2639 |
Currency | EUR - Euro |
You should never invest in AVRICORE HEALTH without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AVRICORE Stock, because this is throwing your money away. Analyzing the key information contained in AVRICORE HEALTH's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AVRICORE HEALTH Key Financial Ratios
Generally speaking, AVRICORE HEALTH's financial ratios allow both analysts and investors to convert raw data from AVRICORE HEALTH's financial statements into concise, actionable information that can be used to evaluate the performance of AVRICORE HEALTH over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that AVRICORE HEALTH INC reports annually and quarterly.Return On Equity | -0.38 | |||
Return On Asset | -0.27 | |||
Beta | -2.13 |
AVRICORE Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AVRICORE HEALTH's current stock value. Our valuation model uses many indicators to compare AVRICORE HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AVRICORE HEALTH competition to find correlations between indicators driving AVRICORE HEALTH's intrinsic value. More Info.AVRICORE HEALTH INC is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value AVRICORE HEALTH by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AVRICORE HEALTH's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AVRICORE HEALTH's earnings, one of the primary drivers of an investment's value.AVRICORE HEALTH INC Systematic Risk
AVRICORE HEALTH's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AVRICORE HEALTH volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Beta measures systematic risk based on how returns on AVRICORE HEALTH INC correlated with the market. If Beta is less than 0 AVRICORE HEALTH generally moves in the opposite direction as compared to the market. If AVRICORE HEALTH Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AVRICORE HEALTH INC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AVRICORE HEALTH is generally in the same direction as the market. If Beta > 1 AVRICORE HEALTH moves generally in the same direction as, but more than the movement of the benchmark.
About AVRICORE HEALTH Financials
What exactly are AVRICORE HEALTH Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include AVRICORE HEALTH's income statement, its balance sheet, and the statement of cash flows. Potential AVRICORE HEALTH investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although AVRICORE HEALTH investors may use each financial statement separately, they are all related. The changes in AVRICORE HEALTH's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AVRICORE HEALTH's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze AVRICORE HEALTH Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as AVRICORE HEALTH is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of AVRICORE has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if AVRICORE HEALTH's financials are consistent with your investment objective using the following steps:- Review AVRICORE HEALTH's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand AVRICORE HEALTH's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare AVRICORE HEALTH's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if AVRICORE HEALTH's stock is overvalued or undervalued.
AVRICORE HEALTH April 17, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AVRICORE HEALTH help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AVRICORE HEALTH INC. We use our internally-developed statistical techniques to arrive at the intrinsic value of AVRICORE HEALTH INC based on widely used predictive technical indicators. In general, we focus on analyzing AVRICORE Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AVRICORE HEALTH's daily price indicators and compare them against related drivers.
Downside Deviation | 7.32 | |||
Information Ratio | 0.0256 | |||
Maximum Drawdown | 44.03 | |||
Value At Risk | (11.56) | |||
Potential Upside | 14.47 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AVRICORE HEALTH INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for AVRICORE Stock analysis
When running AVRICORE HEALTH's price analysis, check to measure AVRICORE HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AVRICORE HEALTH is operating at the current time. Most of AVRICORE HEALTH's value examination focuses on studying past and present price action to predict the probability of AVRICORE HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AVRICORE HEALTH's price. Additionally, you may evaluate how the addition of AVRICORE HEALTH to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |